Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Deferred Tax Assets (Details)

v3.3.1.900
Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Income Tax Disclosure [Abstract]    
Net operating loss carry forwards $ 6,192,058 $ 3,675,012
Patent costs 410,913 318,652
Capitalized interest 85,568 85,568
Accrued vacation 27,852 10,237
Research and development credit 345,721 200,482
Stock based compensation 1,480,266 383,381
Other 5,195 4,460
Gross deferred tax assets 8,547,573 4,677,792
Valuation allowance $ (8,547,573) $ (4,677,792)
Net deferred tax assets